RecruitingPhase 1NCT05094271

Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?


Sponsor

University of California, San Diego

Enrollment

260 participants

Start Date

Jun 30, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Obstructive sleep apnea (OSA) is common in older adults and has recently been implicated in pathogenesis of Alzheimer's disease (AD). Research has shown that sleep disruptions have caused memory impairment. Sleep apnea is a form of sleep disruption. We would like to examine how obstructive sleep apnea may contribute to the progression of Alzheimer's disease.


Eligibility

Min Age: 65 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether obstructive sleep apnea (OSA) — a condition where breathing repeatedly stops during sleep — contributes to the development of Alzheimer's disease in older adults. Researchers will use brain scans and other tests to look for early signs of Alzheimer's in people with and without sleep apnea. **You may be eligible if...** - You are between 65 and 85 years old - You have normal or near-normal thinking and memory (MoCA score > 26) - You live independently and are able to drive - You either have been diagnosed with sleep apnea (AHI ≥ 15/hour) or confirmed to not have it - You are willing to waive access to your Polygenic Health Score (a genetic risk score) during the study **You may NOT be eligible if...** - You currently smoke - You have COPD, asthma, Class III/IV heart failure, or uncontrolled high blood pressure - You have a neurological condition that affects muscle control - You feel excessively sleepy while driving (ESS score > 18) - You cannot have an MRI (e.g., pacemaker, metal implants) - You have a history of brain tumor or major stroke - You have a current drug or alcohol problem Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSupplemental Oxygen

Subjects will be instrumented with a nasal cannula to receive 2L/min supplemental oxygen. The oxygen will be kept at a fixed rate, however, the participant will be titrated to receive a max of 4 liters per min to maintain sats \>90% based on oximetry readings.

DEVICEContinuous Positive Airway Pressure Machine

Continuous positive airway pressure is a form of positive airway pressure ventilation in which a constant level of pressure greater than atmospheric pressure is continuously applied to the upper respiratory tract of a person.

OTHERRoom Air

Subjects will be instrumented with a nasal cannula to receive 2L/min pressurized room air. The room air will be kept at a fixed rate, however, the participant will be titrated to receive a max of 4 liters per min to maintain sats \>90% based on oximetry readings.


Locations(1)

UCSD Sleep Research

La Jolla, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05094271


Related Trials